使用单次呼吸法测量人体运动期间的双重测试气体肺弥散能力
2024年2月2日
该方案提出了一种评估肺泡毛细血管储备的方法，该方法通过联合单次呼吸测量运动期间对一氧化碳（DL，CO）和一氧化氮（DL，NO）的扩散能力进行测量。在锻炼过程中使用该技术的假设和建议构成了本文的基础。
我们的研究重点是各种疾病状态下肺气体交换受损的机制，以及如何将这些知识用于诊断和靶向治疗。我们的目标是通过运动期间的弥散能力测量来评估肺泡毛细血管储备，从而完善对急性运动适应的理解。常规肺功能测试（如动态肺活量测定）和休息期间的弥散量测量，只能提供有关肺功能限制和对急性运动的适应的有限信息。
我们的方案通过引入一种更全面且与生理相关的测量方法来评估肺泡毛细血管储备，从而解决了这一差距。通过对运动过程中的肺功能进行更详细的分析，本研究有助于开发肺部疾病的靶向诊断和治疗策略，提高临床管理和治疗效果。通过这种技术，我们的研究将具体阐明肺气体交换限制如何导致慢性肺病的病理生理学，以及运动训练如何影响慢性肺病。
我们的研究小组打算扩展这项研究，以探索各种治疗和训练干预措施对运动期间肺功能的影响，并调查慢性阻塞性肺疾病患者的具体反应。这将进一步阐明肺部对痛苦的适应性和弹性。
概览
本协议介绍了一种通过运动期间单次呼吸测量碳一氧化物扩散能力（D L,CO）和一氧化氮扩散能力（D L,NO）的组合来评估肺腔-毛细血管储备的方法。本研究旨在通过提供更全面的测量方法来完善对急性运动适应的理解。
关键研究组成部分
科学领域
- 肺生理学
- 运动科学
- 气体交换机制
背景
- 常规肺功能测试提供的信息有限。
- 理解肺气体交换对于诊断肺部疾病至关重要。
- 急性运动适应尚未完全理解。
- 需要更加生理相关的测量方法。
研究目的
- 评估运动期间的肺腔-毛细血管储备。
- 增强肺部疾病的诊断和治疗策略。
- 阐明运动训练对肺气体交换限制的影响。
使用的方法
- 单次呼吸测量扩散能力。
- 在运动条件下进行评估。
- 与常规肺功能测试进行比较。
- 分析气体交换机制。
主要结果
- 引入了一种全面的测量方法。
- 确定运动期间的肺部限制。
- 对慢性肺病的病理生理学有深入见解。
- 可能改善临床管理和治疗效果。
结论
- 该协议解决了当前肺功能测试的不足之处。
- 增强了对运动适应的理解。
- 本研究为更好的诊断策略做出了贡献。
常见问题
Executive Industry Relevance
Quantitative assessment of pulmonary diffusing capacity during exercise addresses a critical gap in understanding alveolar-capillary reserve and gas exchange limitations in both healthy and disease states. This dual test gas single-breath method enables precise evaluation of lung adaptability under physiologic stress, supporting mechanistic de-risking and target validation for respiratory drug discovery. Its reproducibility and scalability position it as a valuable tool for translational research and portfolio triage in pulmonary therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of pulmonary gas exchange mechanisms under exercise stress.
- Supports functional target validation by quantifying alveolar-capillary reserve.
- Facilitates mechanistic de-risking for chronic lung disease models.
- Provides predictive confidence for selecting relevant preclinical endpoints.
Screening & Assay Development
- Delivers standardized, reproducible measurements of DLCO and DLNO during exercise.
- Prepares validated physiological readouts for downstream compound screening.
- Supports assay scalability with up to 12 repeated maneuvers per subject.
- Enables quantitative comparison across intervention and control groups.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for chronic obstructive pulmonary disease and related indications.
- Provides continuity from discovery through preclinical validation of pulmonary interventions.
- Enables risk-adjusted advancement decisions based on exercise-induced gas exchange limitations.
- Supports translational biomarker development for lung adaptability and reserve.
Pipeline & Workflow Integration
This dual gas diffusing capacity measurement integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational validation in disease-relevant models.
- Discovery Biology: Quantifies exercise-induced changes in alveolar-capillary reserve to clarify pulmonary adaptation mechanisms.
- Screening: Provides reproducible, quantitative outputs for evaluating intervention effects on gas exchange.
- Analytics: Generates DLCO and DLNO data for robust statistical comparison across workloads and populations.
- Translational Research: Aligns with clinical endpoints for chronic lung disease and exercise physiology studies.
- Enterprise Reuse: Offers a standardized platform for repeated, cross-study pulmonary function assessment.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in pulmonary research.
- Operational Value: Enhances standardization, reproducibility, and scalability of lung function testing during exercise.
- Strategic Value: Informs go/no-go decisions and improves capital efficiency by identifying functional limitations early.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of respiratory therapeutic candidates.
Implementation Considerations
- Requires expertise in pulmonary physiology and exercise testing protocols.
- Needs specialized instrumentation for single-breath diffusing capacity and gas analysis.
- Demands rigorous calibration and cross-team standardization for reproducible outputs.
- Adaptable across healthy and disease models but may require protocol adjustments for severe impairment.
- Limited by participant ability to perform repeated maximal respiratory maneuvers during exercise.
